Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study.
Sarkar G, Gaikwad VB, Sharma A, Halder SK, Kumar DA, Anand J, Agrawal S, Kumbhar A, Kinholkar B, Mathur R, Doshi M, Bachani D, Mehta S. Sarkar G, et al. Among authors: doshi m. Adv Ther. 2022 Feb;39(2):923-942. doi: 10.1007/s12325-021-01971-9. Epub 2021 Dec 17. Adv Ther. 2022. PMID: 34918194 Clinical Trial.
Efficacy and Safety of Pregabalin Prolonged Release-Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized Study.
Yeole AB, Sree Ranga Lakshmi G, Selvakumar CJ, Goni VG, Nawal CL, Valya BJ, Patel BJ, Patel RD, Pawar ED, Panigrahi R, Kumar AY, Shintre SS, Devkare PH, Dharmadhikari SK, Choudhari SY, Doshi MS, Mehta SC, Joglekar SJ. Yeole AB, et al. Pain Ther. 2022 Dec;11(4):1451-1469. doi: 10.1007/s40122-022-00437-2. Epub 2022 Oct 12. Pain Ther. 2022. PMID: 36224489 Free PMC article.
The Efficacy and Safety of High Dose (10 mg) of Desloratadine (Dazit® 10) in the Treatment of Chronic Spontaneous Urticaria in India: A Phase III, Multicentric, Open-Label, Single-Arm Study.
Kapadia S, Nageswaramma S, Shah K, Singh A, Mahajan SC, Deshpande A, Chakraborty S, Kar BR, Padmaja P, Bharija SC, Doshi M, Ghadge P, Gabhane M, Dharmadhikari S, Mane A, Mehta S. Kapadia S, et al. Among authors: doshi m. Cureus. 2024 Jan 28;16(1):e53125. doi: 10.7759/cureus.53125. eCollection 2024 Jan. Cureus. 2024. PMID: 38420062 Free PMC article.
Efficacy, Safety and Immunogenicity of Sun's Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study.
Ghosh AK, Nikumbh US, Shukla CK, Laul RS, Dixit A, Mahapatra SK, Nayak S, Shah UM, Parwal S, Venkatapathy N, Radhakrishnan N, Kelgaonkar A, Saxena S, Mishra D, Dave VP, Khan P, Saswade MR, Shantilal MS, Ramasamy K, Sreekanta S, Rajurkar M, Doshi M, Behera S, Patel P, Dhawan S, Lakhwani L. Ghosh AK, et al. Among authors: doshi m. Ophthalmol Ther. 2024 May;13(5):1369-1382. doi: 10.1007/s40123-024-00883-5. Epub 2024 Mar 26. Ophthalmol Ther. 2024. PMID: 38530568 Free PMC article.
Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India.
Patel A, Bhatt N, Prakash SS, Biswas G, Nagarkar R, Roy B, Samal P, Agrawal N, Meshram S, Kaushal A, Satheesh CT, Wategaonkar R, Thiagarajan KV, Jain K, Vijayaveeran P, Mukherjee K, Singh K, Patil T, Jain A, Dolai TK, Jain M, Hingmire S, Gupta TC, Lakshmaiah KC, Rajamanickam D, Nemade B, Goyal V, Mahato P, Mendiratta SK, Doshi M. Patel A, et al. Among authors: doshi m. Cancer Chemother Pharmacol. 2023 Jun;91(6):457-468. doi: 10.1007/s00280-023-04530-x. Epub 2023 Apr 24. Cancer Chemother Pharmacol. 2023. PMID: 37093266 Free PMC article. Clinical Trial.
Expanding the access to kidney transplantation: Strategies for kidney transplant programs.
Nishio Lucar AG, Patel A, Mehta S, Yadav A, Doshi M, Urbanski MA, Concepcion BP, Singh N, Sanders ML, Basu A, Harding JL, Rossi A, Adebiyi OO, Samaniego-Picota M, Woodside KJ, Parsons RF. Nishio Lucar AG, et al. Among authors: doshi m. Clin Transplant. 2024 May;38(5):e15315. doi: 10.1111/ctr.15315. Clin Transplant. 2024. PMID: 38686443 Review.
268 results